American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary - PubMed (original) (raw)

. 2013 May-Jun;19(3):536-57.

doi: 10.4158/EP13176.CS.

Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Michael B Davidson, Daniel Einhorn, W Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B Hirsch, Paul S Jellinger, Janet B McGill, Jeffrey I Mechanick, Paul D Rosenblit, Guillermo E Umpierrez, Michael H Davidson

• PMID: 23816937
• PMCID: PMC4142590
• DOI: 10.4158/EP13176.CS

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary

Alan J Garber et al. Endocr Pract. 2013 May-Jun.

No abstract available

PubMed Disclaimer

Similar articles

• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.
  Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Henry RR, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE). Garber AJ, et al. Endocr Pract. 2016 Jan;22(1):84-113. doi: 10.4158/EP151126.CS. Endocr Pract. 2016. PMID: 26731084 No abstract available.
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.
  Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE). Garber AJ, et al. Endocr Pract. 2015 Dec;21(12):1403-14. doi: 10.4158/EP151063.CS. Endocr Pract. 2015. PMID: 26642101
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
  Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. Garber AJ, et al. Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17. Endocr Pract. 2018. PMID: 29368965 No abstract available.
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.
  Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI, Blonde L, Bush MA, DeFronzo RA, Garber JR, Garvey WT, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Perreault L, Rosenblit PD, Samson S, Umpierrez GE. Garber AJ, et al. Endocr Pract. 2020 Jan;26(1):107-139. doi: 10.4158/CS-2019-0472. Endocr Pract. 2020. PMID: 32022600 No abstract available.
• Diabetes mellitus in childhood: a review.
  Drash A. Drash A. J Pediatr. 1971 Jun;78(6):919-41. doi: 10.1016/s0022-3476(71)80421-3. J Pediatr. 1971. PMID: 4325222 Review. No abstract available.

Cited by

• Total iridoid glycoside extract of Lamiophlomis rotata (Benth) Kudo accelerates diabetic wound healing by the NRF2/COX2 axis.
  Geng X, Wang Y, Li H, Song L, Luo C, Gu X, Zhong H, Chen H, Chen X, Wang J, Pan Z. Geng X, et al. Chin Med. 2024 Mar 22;19(1):53. doi: 10.1186/s13020-024-00921-1. Chin Med. 2024. PMID: 38519940 Free PMC article.
• The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial.
  Candás-Estébanez B, Fernández-Cidón B, Corbella E, Tebé C, Fanlo-Maresma M, Esteve-Luque V, Salas-Salvadó J, Fitó M, Riera-Mestre A, Ros E, Pintó X. Candás-Estébanez B, et al. Int J Mol Sci. 2024 Jan 22;25(2):1338. doi: 10.3390/ijms25021338. Int J Mol Sci. 2024. PMID: 38279337 Free PMC article. Clinical Trial.
• Smokeless Tobacco Use and Its Association with Type 2 Diabetes: A Case Control Study.
  Sawane H, Rajpurohit L, Sonawane S, Kharat P, Mathur A. Sawane H, et al. Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4209-4217. doi: 10.31557/APJCP.2023.24.12.4209. Asian Pac J Cancer Prev. 2023. PMID: 38156856 Free PMC article.
• Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.
  Bays HE, Fitch A, Christensen S, Burridge K, Tondt J. Bays HE, et al. Obes Pillars. 2022 Apr 15;2:100018. doi: 10.1016/j.obpill.2022.100018. eCollection 2022 Jun. Obes Pillars. 2022. PMID: 37990711 Free PMC article.
• Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
  Sahay RK, Giri R, Shembalkar JV, Gupta SK, Mohan B, Kurmi P, Kumar SR, Sawardekar VM, Mishra A, Murthy LS, Arya VV, Sonawane AR, Soni PN, Gofne SK, Karnawat SR, Rajurkar MN, Patel PM, Lakhwani LK, Mehta SC, Joglekar SJ. Sahay RK, et al. Adv Ther. 2023 Jul;40(7):3227-3246. doi: 10.1007/s12325-023-02523-z. Epub 2023 May 31. Adv Ther. 2023. PMID: 37258803 Clinical Trial.

References

1. 1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–110. - PubMed
2. 1. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists’ position statement on obesity and obesity medicine. Endocr Pract. 2012;18:642–648. - PubMed
3. 1. Bray GA, Ryan DH. Medical therapy for the patient with obesity. Circulation. 2012;125:1695–1703. - PubMed
4. 1. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109:706–713. - PubMed
5. 1. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640–1649. - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information